Ignite Creation Date:
2025-12-25 @ 12:59 AM
Ignite Modification Date:
2026-01-03 @ 9:38 PM
Study NCT ID:
NCT03388593
Status:
RECRUITING
Last Update Posted:
2024-02-01
First Post:
2017-12-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Survival Study of the Recombinant Human Neuregulin-1β in Subjects With Chronic Heart Failure.
Sponsor:
Zensun Sci. & Tech. Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-23
Start Date Type:
ACTUAL
Primary Completion Date:
2026-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-02
Completion Date Type:
ESTIMATED
First Submit Date:
2017-12-19
First Submit QC Date:
None
Study First Post Date:
2018-01-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-30
Last Update Post Date:
2024-02-01
Last Update Post Date Type:
ACTUAL